To investigate the potential cause for these significant alterations in the sensitivity to MEKi, we carried out unsupervised hierarchical clustering of 11 KRAS-mutant pancreatic cancer cell lines from the Cancer Cell Line Encyclopedia (CCLE). The gene discussed is KRAS; the disease is pancreatic neoplasm.